Prospidium
|
- $199 - $1540
- Product name: Prospidium
- CAS: 23476-83-7
- MF: C18H36Cl4N4O2
- MW: 482.33
- EINECS:
- MDL Number:MFCD00357496
- Synonyms:3,12-Bis(3-chloro-2-hydroxypropyl)-3,12-diaza-6,9-diazoniadispiro[5.2.5.2]hexadecane dichlorid;Prospidium;Prospidin;3,12-Bis(3-chloro-2-hydroxypropyl)-3,12-diaza-6,9-diazoniadispiro[5.2.5.2]hexadecane dichloride;3,12-Diaza-6,9-diazoniadispiro[5.2.5.2]hexadecane, 3,12-bis(3-chloro-2-hydroxypropyl)-, dichloride;Nsc166100;Prospidine;3,12-Bis(3-chloro-2-hydroxypropyl)-3,6,9,12-tetraazadispiro[5.2.5(9).2(6)]Hexadecane-6,9-diium chloride
3 prices
Selected condition：
Brand
- Aronis compounds
- Matrix Scientific
- TRC
Package
- 50mg
- 500mg
- 5g
- ManufacturerAronis compounds
- Product numberBBC/238
- Product description3,12-bis(3-chloro-2-hydroxypropyl)-3,12-diaza-6,9-diazoniadispiro[5.2.5.2]hexadecanedichloride
- Packaging5g
- Price$373
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number058357
- Product description3,12-Bis(3-chloro-2-hydroxypropyl)-3,12-diaza-6,9-diazoniadispiro[5.2.5.2]hexadecane dichloride
- Packaging500mg
- Price$199
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberP838500
- Product descriptionProspidiumChloride
- Packaging50mg
- Price$1540
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Aronis compounds | BBC/238 | 3,12-bis(3-chloro-2-hydroxypropyl)-3,12-diaza-6,9-diazoniadispiro[5.2.5.2]hexadecanedichloride | 5g | $373 | 2021-12-16 | Buy |
| Matrix Scientific | 058357 | 3,12-Bis(3-chloro-2-hydroxypropyl)-3,12-diaza-6,9-diazoniadispiro[5.2.5.2]hexadecane dichloride | 500mg | $199 | 2021-12-16 | Buy |
| TRC | P838500 | ProspidiumChloride | 50mg | $1540 | 2021-12-16 | Buy |
Properties
Density :1.3032 (rough estimate)
refractive index :1.6100 (estimate)
refractive index :1.6100 (estimate)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|